Who Supplies Cytarabine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Cytarabine exports, with 175+ registered manufacturers shipping to buyers across 110+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 17.2% (export value: $1.8M). Close behind, FRESENIUS KABI ONCOLOGY LIMITED (7.9%, $853.0K). ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (4.6%, $498.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Cytarabine? Top Manufacturers & Their Buyers
Flow of Cytarabine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Cytarabine Supplier Network — Key Market Intelligence
The Cytarabine export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 17.2% share, shipping $1.8M worth of product across 693 shipments. The second-largest exporter, FRESENIUS KABI ONCOLOGY LIMITED, contributes $853.0K (7.9%) to the overall market. Combined, the top two suppliers alone account for 25.2% of all Cytarabine exports, indicating a relatively concentrated supply base.
Across all 175 tracked manufacturers, the total Cytarabine export value stands at $10.7M from 1.8K shipments. The market average shipment value is $5.9K. The single largest buyer relationship in terms of trade value is ACCORD FARMACUTICA LIMITEDA, receiving $460.3K worth of product.
The combined buyer network spans 15 named purchasing companies, including ACCORD FARMACUTICA LIMITEDA, ALLOGA FRANCE, FRESENIUS KABI SOUTH AFRICA (PTY) L, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI MALAYSIA SDN BHD and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the first-largest Cytarabine exporter from India, with a market share of 17.2% and a total export value of $1.8M across 693 shipments. Their average shipment value of $2.7K is below the market average of $5.9K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $502.1K across 188 shipments (27.1% of this supplier's total exports)
• ACCORD FARMACUTICA LIMITEDA — $460.3K across 172 shipments (24.9% of this supplier's total exports)
• ALLOGA FRANCE — $345.8K across 130 shipments (18.7% of this supplier's total exports)
• ACCORD FARMACUTICA LIMITEDA — $284.8K across 107 shipments (15.4% of this supplier's total exports)
• ACCORD FARMACUTICA LIMITEDA — $256.8K across 96 shipments (13.9% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (693 shipments) at a per-shipment value of $2.7K, indicating a broad distribution network with many smaller, regular orders.
2FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the second-largest Cytarabine exporter from India, with a market share of 7.9% and a total export value of $853.0K across 98 shipments. Their average shipment value of $8.7K is above the market average of $5.9K, suggesting premium or bulk contract pricing.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FRESENIUS KABI SOUTH AFRICA (PTY) L — $217.9K across 25 shipments (25.5% of this supplier's total exports)
• FRESENIUS KABI (THAILAND) LTD., — $211.5K across 24 shipments (24.8% of this supplier's total exports)
• FRESENIUS KABI MALAYSIA SDN BHD — $174.4K across 20 shipments (20.4% of this supplier's total exports)
• FRESENIUS KABI SOUTH AFRICA (PTY) L — $134.7K across 15 shipments (15.8% of this supplier's total exports)
• FRESENIUS KABI SOUTH AFRICA (PTY) L — $114.6K across 13 shipments (13.4% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED's per-shipment value of $8.7K is 48% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.
3ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED is the third-largest Cytarabine exporter from India, with a market share of 4.6% and a total export value of $498.8K across 11 shipments. Their average shipment value of $45.3K is above the market average of $5.9K, suggesting premium or bulk contract pricing.
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED serves 2 named buyers in our database. PFIZER SERVICE COMPANY BV is the dominant customer, accounting for 50.6% of this supplier's tracked business. Top customers include:
• PFIZER SERVICE COMPANY BV — $252.6K across 6 shipments (50.6% of this supplier's total exports)
• XXIZEXXSERXXCE XXMPAXX BV — $246.2K across 5 shipments (49.4% of this supplier's total exports)
Key Insight: ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED's per-shipment value of $45.3K is 670% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.
4NAPROD LIFE SCIENCES PRIVATE LIMITED
NAPROD LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Cytarabine exporter from India, with a market share of 4.6% and a total export value of $490.8K across 52 shipments. Their average shipment value of $9.4K is above the market average of $5.9K, suggesting premium or bulk contract pricing.
NAPROD LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. MULTICARE PHARMACEUTICALS PHILIPPIN is the dominant customer, accounting for 55.6% of this supplier's tracked business. Top customers include:
• MULTICARE PHARMACEUTICALS PHILIPPIN — $272.7K across 29 shipments (55.6% of this supplier's total exports)
• MULTICARE PHARMACEUTICALS PHILIPPIN — $72.2K across 8 shipments (14.7% of this supplier's total exports)
• SEVEN PHARMA S A C — $68.8K across 7 shipments (14.0% of this supplier's total exports)
• AL PHARMA S A S DESC — $61.6K across 7 shipments (12.5% of this supplier's total exports)
• MULTICARE PHARMACEUTICALS PHILIPPIN — $15.5K across 2 shipments (3.2% of this supplier's total exports)
Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $9.4K is 60% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.
5RUS MED EXPORTS PVT. LTD.
RUS MED EXPORTS PVT. LTD. is the fifth-largest Cytarabine exporter from India, with a market share of 1.9% and a total export value of $202.5K across 16 shipments. Their average shipment value of $12.7K is above the market average of $5.9K, suggesting premium or bulk contract pricing.
RUS MED EXPORTS PVT. LTD. serves 2 named buyers in our database. M/S MANAS MED is the dominant customer, accounting for 95.4% of this supplier's tracked business. Top customers include:
• M/S MANAS MED — $193.2K across 15 shipments (95.4% of this supplier's total exports)
• M/S.MANASH MED — $9.3K across 1 shipments (4.6% of this supplier's total exports)
Key Insight: RUS MED EXPORTS PVT. LTD.'s per-shipment value of $12.7K is 115% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.
6CELON LABORATORIES PRIVATE LIMITED
CELON LABORATORIES PRIVATE LIMITED is the fifth-largest Cytarabine exporter from India, with a market share of 1.1% and a total export value of $113.4K across 44 shipments. Their average shipment value of $2.6K is below the market average of $5.9K, reflecting a high-volume, competitive pricing strategy.
CELON LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SEVEN PHARMA EL SALV — $42.7K across 17 shipments (37.7% of this supplier's total exports)
• SEVEN PHARMA S A C — $26.9K across 10 shipments (23.7% of this supplier's total exports)
• I.E MEDICA INC — $16.0K across 6 shipments (14.1% of this supplier's total exports)
• SEVEN PHARMA DEL ECU — $14.0K across 5 shipments (12.3% of this supplier's total exports)
• I.E MEDICA INC — $13.8K across 5 shipments (12.2% of this supplier's total exports)
Key Insight: CELON LABORATORIES PRIVATE LIMITED operates with high shipment frequency (44 shipments) at a per-shipment value of $2.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Cytarabine Flows
Once Cytarabine leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and FRESENIUS KABI ONCOLOGY LIMITED, it travels to 5 destination markets with a combined import value of $10.7M. Netherlands absorbs the largest share at 13.5% ($1.4M), followed by Brazil (12.5%) and United Kingdom (5.0%).
In Netherlands — the top destination — named importers include ALLOGA FRANCE, BROCACEF NL : HUB. In Brazil, key buyers are ACCORD FARMACUTICA LTDA, ACCORD FARMACUTICA LTDA., ACCORD FARMACUTICA LIMITEDA.
This geographic spread reflects Cytarabine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Cytarabine Go? Top Importing Countries & Their Buyers
Trade flow of Cytarabine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Netherlands
Netherlands ranks as the first-largest destination for Cytarabine imports from India, with a total trade value of $1.4M across 78 shipments — representing a 13.5% share of all Cytarabine exports. The average shipment value of $18.5K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cytarabine importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 36.7% ($530.3K) of this market's total imports.
• ALLOGA FRANCE — $530.3K (36.7% of Netherlands's total)
• BROCACEF NL : HUB — $385.2K (26.6% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $18.5K (215% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Cytarabine imports from India.
2Brazil
Brazil ranks as the second-largest destination for Cytarabine imports from India, with a total trade value of $1.3M across 29 shipments — representing a 12.5% share of all Cytarabine exports. The average shipment value of $46.2K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Cytarabine importers in Brazil: ACCORD FARMACUTICA LTDA is the largest buyer, accounting for 34.3% ($460.3K) of this market's total imports.
• ACCORD FARMACUTICA LTDA — $460.3K (34.3% of Brazil's total)
• ACCORD FARMACUTICA LTDA. — $334.3K (24.9% of Brazil's total)
• ACCORD FARMACUTICA LIMITEDA — $256.8K (19.2% of Brazil's total)
Key Insight: Brazil's per-shipment average of $46.2K (685% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Cytarabine imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Cytarabine imports from India, with a total trade value of $542.4K across 25 shipments — representing a 5.0% share of all Cytarabine exports. The average shipment value of $21.7K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Cytarabine importers in United Kingdom: ACCORD UK is the largest buyer, accounting for 81.4% ($441.7K) of this market's total imports.
• ACCORD UK — $441.7K (81.4% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $21.7K (268% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Cytarabine imports from India.
4Australia
Australia ranks as the fourth-largest destination for Cytarabine imports from India, with a total trade value of $517.7K across 0 shipments — representing a 4.8% share of all Cytarabine exports. The average shipment value of $517.7K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: Australia's per-shipment average of $517.7K (8694% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Cytarabine imports from India.
5South Africa
South Africa ranks as the fifth-largest destination for Cytarabine imports from India, with a total trade value of $489.1K across 6 shipments — representing a 4.6% share of all Cytarabine exports. The average shipment value of $81.5K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cytarabine importers in South Africa: FRESENIUS KABI SOUTH AFRICA PTY LT is the largest buyer, accounting for 44.6% ($217.9K) of this market's total imports.
• FRESENIUS KABI SOUTH AFRICA PTY LT — $217.9K (44.6% of South Africa's total)
• FRESENIUS KABI SOUTH AFRICA (PTY) L — $134.7K (27.5% of South Africa's total)
Key Insight: South Africa's per-shipment average of $81.5K (1285% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Cytarabine imports from India.
People Also Ask — Cytarabine Supplier & Trade Network
Who are the top suppliers of Cytarabine from India?+
Which companies buy Cytarabine from Indian manufacturers?+
Where does Cytarabine exported from India go?+
What is the market share of the top Cytarabine supplier from India?+
What is the average shipment value for Cytarabine exports from India?+
Is Cytarabine manufactured in India and exported globally?+
Which country imports the most Cytarabine from India?+
Who are the buyers of Cytarabine in Brazil?+
How concentrated is the Cytarabine supplier market in India?+
How do I find verified buyers for Cytarabine in specific countries?+
Cytarabine Trade Network — Key Takeaways
- 1INTAS PHARMACEUTICALS LIMITED is India's dominant Cytarabine exporter with a 17.2% market share and $1.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 175 suppliers collectively account for 37.3% of all tracked Cytarabine exports, with a combined trade value of $10.7M.
- 3Netherlands is the largest destination market, absorbing 13.5% of India's Cytarabine exports ($1.4M). Brazil (12.5%) and United Kingdom (5.0%) follow.
- 4With 1.8K total shipments averaging $5.9K each, the Cytarabine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ACCORD FARMACUTICA LIMITEDA, ALLOGA FRANCE, FRESENIUS KABI SOUTH AFRICA (PTY) L, FRESENIUS KABI (THAILAND) LTD., — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 110 countries
Network value: $10.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cytarabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cytarabine.
- 2.Flow Mapping: 175 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,825 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 110 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,825 Verified Shipments
175 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists